New research suggests that weight gained in the first 12 weeks of antipsychotic treatment is the biggest driver of long-term obesity in psychosis.
[read the full story...]
New research suggests that weight gained in the first 12 weeks of antipsychotic treatment is the biggest driver of long-term obesity in psychosis.
[read the full story...]
Only 35% of people with severe mental illness received all six cardiovascular risk factor checks within one month in this UK primary care study. Financial incentives temporarily increased comprehensive screening but effects were uneven and short-lived. Young men of non-White ethnicity were most likely to miss screening, highlighting persistent inequalities.
[read the full story...]
A 15-year analysis of UK primary care records showed steep and sustained weight gain after an SMI diagnosis, especially among younger adults and people prescribed antipsychotic medication. Yet very few received referrals for weight-management support, raising important questions about practice and policy.
[read the full story...]
Mindfulness-based approaches show early promise for people with Parkinson’s, but the evidence is small, scattered, and underpowered. This systematic review maps what we know, what we don’t, and why psychological care needs far more attention in Parkinson’s services.
[read the full story...]
Alcohol causes 2.6 million premature deaths each year, yet remains the world’s favourite drug. This new global analysis exposes how weak policy, powerful industry lobbying and slow action are undermining WHO’s efforts to reduce alcohol-related harm.
[read the full story...]
People with severe mental illness are more than twice as likely to die from respiratory disease than those without. This new systematic review highlights the scale of the problem and why action on public health and social inequality is just as vital as stop-smoking advice.
[read the full story...]
How safe is it to treat ADHD in people with schizophrenia spectrum disorders? New long-term data offers pragmatic reassurance, but also some warnings.
[read the full story...]
No drugs are officially approved for borderline personality disorder, yet prescribing is widespread. This systematic review explores why clinicians prescribe, the pressures they face, and what it means for patient care.
[read the full story...]
With dementia rates rising fast, prevention is critical. But do countries’ plans reflect that urgency? This new paper analyses 16 national dementia strategies—and finds good intentions often aren’t backed by clear actions.
[read the full story...]
Dona Mathews highlights a new study showing a doubled risk of depression after a medical diagnosis – especially in the first month post-diagnosis, for those who are hospitalised for their medical condition, those with multiple medical conditions, those over 60, and for women.
[read the full story...]